Skip to Main Content

Author Details

Adam A Kraya
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
2015
12
7
PMIDPaper TitleJournal TitlePublished Year
37978951Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.J Clin Oncol2024
37978951Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.J Clin Oncol2024
37337080Radiomics for characterization of the glioma immune microenvironment.NPJ Precis Oncol2023
37337080Radiomics for characterization of the glioma immune microenvironment.NPJ Precis Oncol2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
35201851<i>PTEN</i> Loss and <i>BRCA1</i> Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer.JCO Precis Oncol2022
36344544Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers.Nat Commun2022
35852795Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.Clin Cancer Res2022
35201851<i>PTEN</i> Loss and <i>BRCA1</i> Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer.JCO Precis Oncol2022
35852795Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.Clin Cancer Res2022
36344544Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers.Nat Commun2022
33941922Evolution of delayed resistance to immunotherapy in a melanoma responder.Nat Med2021
33941922Evolution of delayed resistance to immunotherapy in a melanoma responder.Nat Med2021
30914433Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer.Clin Cancer Res2019
30914433Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer.Clin Cancer Res2019
31365035Association of Filaggrin Loss-of-Function Variants With Race in Children With Atopic Dermatitis.JAMA Dermatol2019
31365035Association of Filaggrin Loss-of-Function Variants With Race in Children With Atopic Dermatitis.JAMA Dermatol2019
29428354Uncommon Filaggrin Variants Are Associated with Persistent Atopic Dermatitis in African Americans.J Invest Dermatol2018
29428354Uncommon Filaggrin Variants Are Associated with Persistent Atopic Dermatitis in African Americans.J Invest Dermatol2018
28831036BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.Nat Commun2017
28831036BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.Nat Commun2017
25484078Identification of secreted proteins that reflect autophagy dynamics within tumor cells.Autophagy2015
25484078Identification of secreted proteins that reflect autophagy dynamics within tumor cells.Autophagy2015
  • 1 - 24 of 24

Recommended Authors

Washington University School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Washington University in St Louis
Career Start Year 2015
Number of shared co-authors 2
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center (MSKCC)
Career Start Year 2015
Number of shared co-authors 0
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
BC Cancer Research Institute
Career Start Year 2014
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 1
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 2
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 1
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 0
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 1
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 4
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2006
Number of shared co-authors 1
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 3
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 0
Washington University
Career Start Year 2003
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 8
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 1
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 1
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 1
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 2

Collaborators

Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 7
Co-authored papers 4
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 4
University of California san francisco
Co-authored papers 3
Co-authored papers 3
Children's Hospital of Philadelphia
Co-authored papers 2
Children's Hospital of Philadelphia
Co-authored papers 2
USA University of Zurich
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 2
Maharaja Agrasen Medical College
Co-authored papers 2
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 2
Children's Hospital of Philadelphia
Co-authored papers 2
University Children's Hospital Zurich
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 1
Children's Hospital of Philadelphia
Co-authored papers 1
Co-authored papers 1
Children's Hospital of Philadelphia
Co-authored papers 1
Co-authored papers 1
Hasbro Children's Hospital, Brown University.
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 1
Massachusetts Institute of Technology
Co-authored papers 1
Co-authored papers 1